BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio's pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. Goodwin's product team included Jim Barri, Kim de Glossop and Nikki Miller. Goodwin's corporate team included Maggie Wong, Natalie T. Martirossian, Alicia Tschirhart, Claire Treesh, Dan Liu and Harper Vincent. Dan Karelitz and Garrett Gaughan provided tax advice.